- Home
- GELS vs AEI Comparison
GELS vs AEI Comparison
Compare GELS & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GELS
- AEI
- Stock Information
- Founded
- GELS 2018
- AEI 2014
- Country
- GELS Australia
- AEI United States
- Employees
- GELS N/A
- AEI N/A
- Industry
- GELS
- AEI Building operators
- Sector
- GELS
- AEI Real Estate
- Exchange
- GELS NYSE
- AEI Nasdaq
- Market Cap
- GELS 8.7M
- AEI 8.8M
- IPO Year
- GELS 2024
- AEI N/A
- Fundamental
- Price
- GELS $1.90
- AEI $0.95
- Analyst Decision
- GELS
- AEI
- Analyst Count
- GELS 0
- AEI 0
- Target Price
- GELS N/A
- AEI N/A
- AVG Volume (30 Days)
- GELS 4.7M
- AEI 40.3K
- Earning Date
- GELS 02-15-2025
- AEI 05-14-2025
- Dividend Yield
- GELS N/A
- AEI N/A
- EPS Growth
- GELS N/A
- AEI N/A
- EPS
- GELS N/A
- AEI N/A
- Revenue
- GELS $95,618.00
- AEI $21,115,899.00
- Revenue This Year
- GELS N/A
- AEI N/A
- Revenue Next Year
- GELS N/A
- AEI N/A
- P/E Ratio
- GELS N/A
- AEI N/A
- Revenue Growth
- GELS N/A
- AEI N/A
- 52 Week Low
- GELS $0.77
- AEI $0.46
- 52 Week High
- GELS $5.50
- AEI $2.61
- Technical
- Relative Strength Index (RSI)
- GELS N/A
- AEI 57.00
- Support Level
- GELS N/A
- AEI $0.79
- Resistance Level
- GELS N/A
- AEI $1.00
- Average True Range (ATR)
- GELS 0.00
- AEI 0.09
- MACD
- GELS 0.00
- AEI 0.01
- Stochastic Oscillator
- GELS 0.00
- AEI 83.33
About GELS GELTEQ LIMITED
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.